Acadia Healthcare Company, Inc. announced the appointment of Dr. Stephanie Eken as the Company?s new chief medical officer. Dr. Eken is a psychiatrist with more than two decades of experience across the spectrum of behavioral health. In this role, Dr. Eken will lead the clinical strategy for Acadia, across more than 250 facilities in 38 states including Puerto Rico.

Additionally, Dr. Eken will help drive business direction by infusing her clinical expertise into vital decision-making to ensure Acadia's culture and standards of excellence are consistent across its continuum of care. She is also a member of the Company?s executive leadership team. Dr. Eken brings more than two decades of experience across the behavioral health domain into this new role.

She joins Acadia after spending 15 years at Rogers Behavioral Health, a not-for-profit, nationwide independent provider of specialized mental health and addiction treatment. At Rogers, she most recently served as chief medical officer, partnering with the system?s executive leadership to lead patient care, quality, and facilities expansion. A triple board-certified physician, Dr. Eken is a graduate of the University of Tennessee College of Medicine, and completed post-graduate training in pediatrics, psychiatry, and child and adolescent psychiatry.

Early in her career, Dr. Eken focused heavily on child and adolescent psychiatry, pioneering a variety of treatments in specialty programs. Dr. Eken succeeds Dr. Michael Genovese, who will continue in a consulting role for several months to aid in a smooth transition. Dr. Genovese departs Acadia after 10 years with the Company, seven of those as its chief medical officer.